Skip to main content
menu

IMLEU22029 // PKRPC001 // Huselton

Basic Study Information

Purpose:
This is a multi-center, randomized, double-blinded, placebo controlled trial.

Location: University of Rochester Medical Center (URMC)

Lead Researcher (Principal Investigator)

Lead Researcher:  Eric Huselton

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Return to Search